EZH2 and depressive symptom measurement: To verify the role of miR-29b-3p in depression, miR-29b-3p inhibitor was transfected into cells in the sh-EZH2 group to successfully reduce intracellular miR-29b-3p expression (p < 0.01, Figure 6(a)).